Jacqueline Birks

Suggest Changes
Learn More
BACKGROUND The objective was to evaluate the efficacy and tolerability of donepezil (5 and 10 mg/day) compared with placebo in alleviating manifestations of mild to moderate Alzheimer's disease (AD).(More)